Alnylam Pharmaceuticals, Inc.

Skandinaviska Enskilda Banken AB (publ) ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

66,218

Value ($000)

26,332

Weight

0.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	26,332	0.1%	66,218	12/31/2025
2025 Q3	11/7/2025	36,297	0.1%	79,652	9/30/2025
2025 Q2	8/13/2025	27,675	0.1%	84,888	6/30/2025
2025 Q1	5/7/2025	23,269	0.1%	86,124	3/31/2025
2024 Q4	2/10/2025	29,623	0.1%	125,491	12/31/2024
2024 Q3	11/7/2024	41,284	0.2%	150,119	9/30/2024
2024 Q2	8/13/2024	25,967	0.1%	106,892	6/30/2024
2024 Q1	5/13/2024	14,124	0.1%	94,553	3/31/2024
2023 Q4	2/14/2024	17,862	0.1%	93,257	12/31/2023
2023 Q3	11/9/2023	16,495	0.1%	93,225	9/30/2023
2023 Q2	8/7/2023	17,630	0.1%	92,821	6/30/2023
2023 Q1	5/11/2023	25,344	0.2%	126,520	3/31/2023
2022 Q4	2/8/2023	21,761	0.2%	91,566	12/31/2022
2022 Q3	11/14/2022	23,306	0.2%	116,439	9/30/2022
2022 Q2	8/10/2022	13,204	0.1%	90,534	6/30/2022
2022 Q1	5/11/2022	6,021	0.0%	36,873	3/31/2022
2021 Q4	2/10/2022	7,951	0.0%	46,489	12/31/2021
2021 Q3	11/10/2021	7,796	0.0%	41,289	9/30/2021
2021 Q2	8/10/2021	8,419	0.1%	49,664	6/30/2021
2021 Q1	5/14/2021	3,962	0.0%	28,061	3/31/2021
2020 Q4	2/11/2021	3,434	0.0%	26,422	12/31/2020
2020 Q3	11/12/2020	3,952	0.0%	27,143	9/30/2020
2020 Q2	8/13/2020	3,340	0.0%	22,554	6/30/2020
2020 Q1	5/13/2020	1,761	0.0%	16,180	3/31/2020
2019 Q4	2/14/2020	2,457	0.0%	21,330	12/31/2019